The current issued share capital of the Company, including shares issued under its blocklisting facility, is 1,788,827,700 ordinary shares. No shares are held as treasury.
The Directors (together with their families and their family trusts and pension scheme arrangements) in aggregate hold 32,272,045 ordinary shares in the Company, representing 1.804% of the Company’s current issued share capital.
27.82% of the issued share capital was not in public hands.
The Company is aware of the following significant (3% or greater) shareholdings in the Company’s ordinary shares:
|Number of ordinary shares||% of issued share capital|
|Woodford Investment Management||26.10%|
|The Wales Life Sciences Investment Fund LP||11.18%|
|Abingworth Bioventures VI LP||5.28%|
The above information was last updated on Friday, 29 May 2015